Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US
10 Dec 2024 //
FDA
23andMe Releases New FDA-Cleared Genetic Report on Simvastatin
20 Jul 2023 //
GLOBENEWSWIRE
Enforcement Report - Week of May 10, 2023
10 May 2023 //
FDA
Enforcement Report - Week of April 12, 2023
12 Apr 2023 //
FDA
Enforcement Report - Week of April 5, 2023
05 Apr 2023 //
FDA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Enforcement Report - Week of November 17, 2021
17 Nov 2021 //
FDA
Enforcement Report - Week of November 11, 2021
10 Nov 2021 //
FDA
Use of 10p statins in organ donation ‘could save thousands of lives’
19 Sep 2021 //
THE GUARDIAN
Aurobindo recalls 2,352 bottles of statins from US market
10 Sep 2019 //
INPHARMATECHNOLOGIST
Enforcement Report - Week of September 4, 2019
04 Sep 2019 //
FDA
ImmunogenX Completes CypCel Trial for Celiac Disease
27 Sep 2018 //
BUSINESSWIRE
Landmark MS trial launches in UK
14 Sep 2018 //
PHARMA TIMES
FTC imposes conditions on Amneal acquisition of Impax
11 Jul 2018 //
PHARMA LETTER
ANI Pharmaceuticals Completes Acq.of Generic Products & Assets from Amneal/Impax
07 May 2018 //
PR NEWSWIRE
Enforcement Report - Week of January 24, 2018
24 Jan 2018 //
FDA
Alkem Labs Generic Ezetimibe; Simvastatin Receives Approval In US
28 Dec 2017 //
FDA
Amneal Pharm’s Generic Ezetimibe; Simvastatin Receives Approval In US
22 Nov 2017 //
FDA
Hisun Pharm Hangzhou’s Generic Simvastatin Receives Approval In US
16 Nov 2017 //
FDA
Merck plots 1,800 sales layoffs and new chronic care focus
21 Oct 2017 //
FIERCE PHARMA
Stopping cholesterol-lowering drugs could be deadly
26 Jul 2017 //
REUTERS
Stampeding generics expected to trample Lilly`s now-off-patent med Strattera
01 Jun 2017 //
FIERCE PHARMA
Momentous’ UK trial to explore statin for MS
09 May 2017 //
PHARMA TIMES
Watson Labs Generics Ezetimibe; Simvastatin Receives Approval In US
27 Apr 2017 //
FDA
Impax Labs Generics Ezetimibe; Simvastatin Receives Approval In US
27 Apr 2017 //
FDA
Dr Reddys Labs Intl Generics Ezetimibe; Simvastatin Receives Approval In US
27 Apr 2017 //
FDA
Merck falls short in Q4 sales but sees EPS growth ahead
02 Feb 2017 //
FIERCE PHARMA
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
18 Jan 2017 //
FIERCE PHARMA
Corden announces completion of new highly potent API process
17 Oct 2016 //
PRESS RELEASE
Artemis Biotech Fails EDQM Inspection
11 Aug 2016 //
EDQM
Inefficient prescribing costs billions of healthcare dollars
09 May 2016 //
REUTERS
Biocon Inc recalls 5,505 bottles of Simvastatin
21 Apr 2016 //
ET HEALTH WORLD
Cadila receives Indian process patent for Sitagliptin (Januvia)
01 Mar 2016 //
TWOFOUR INSIGHT
Merck says U.S. FDA reject its claim that Zetia and Vytorin cut heart risk
16 Feb 2016 //
REUTERS
Merck`s Vytorin Study Epitomizes Inherent Risks Of Major Clinical Trials
16 Dec 2015 //
FORBES
Merck fails to win FDA panel backing for Vytorin heart claim
15 Dec 2015 //
REUTERS
Heart drugs often unavailable or unaffordable
14 Nov 2015 //
REUTERS
Cholesterol,TB Drugs Recalled in Philippines Due to Failed Dissolution Tests
08 Oct 2015 //
NEWS INFERNO
Advera Health Analytics: Merck statins linked to more muscle side effects than rest of class
15 Sep 2015 //
FIERCE PHARMA
Treato Finds Demand Will be High for Heart Failure Drug Entresto
09 Sep 2015 //
PR NEWS WIRE
Where Are The ‘Five Stars’ Merck Got From Schering-Plough?
10 Apr 2015 //
PHARMALOT
Should 500K more young people be on statins? Guidelines say yes, JAMA reports
08 Apr 2015 //
FIERCE PHARMA
FDA Warns vs 20 Unregistered Drugs
23 Mar 2015 //
INQUIRER.NET
India`s Micro Labs Recalls Cholesterol Med
20 Mar 2015 //
FDA
Report Card: FDA Earns a Solid
25 Jan 2015 //
FDA LAW BLOG